This article is more than 5 years old. Information may no longer be current.

Nipro Medical introduces Elisio Polynephron dialyzer

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Nipro Medical Corporation has received 510(K) clearance from the U.S. Food and Drug Administration for its Elisio Polynephron single use, high-flux, hollow-fiber dialyzer. The Elisio features a Polynephron membrane similar in function to that of a human kidney, and delivers excellent biocompatibility, hemocompatibility, and solute-removal performance, resulting in superior clearances for better patient outcomes, according to a news release from Nipro.

“Elisio is designed to deliver an elevated benefits platform to the market, especially in clearance performance of small to middle molecules, and it delivers on these objectives,” said Joe Dawson, Senior Vice President of Nipro North America.